Increased Cancer Prevalence in Peripartum Cardiomyopathy
Objectives: This study was designed to analyze the prevalence and potential genetic basis of cancer and heart failure in peripartum cardiomyopathy (PPCM). Background: PPCM manifests as heart failure late in pregnancy or postpartum in women without previous heart disease. Methods: Clinical history an...
Main Authors: | Tobias J. Pfeffer, MD, Stella Schlothauer, MS, Stefan Pietzsch, PhD, Maria Schaufelberger, MD, Bernd Auber, MD, Melanie Ricke-Hoch, PhD, Manuel List, MS, Dominik Berliner, MD, Valeska Abou Moulig, MD, Tobias König, MD, Zolt Arany, MD, PhD, Karen Sliwa, MD, Johann Bauersachs, MD, Denise Hilfiker-Kleiner, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | JACC. CardioOncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266608731930081X |
Similar Items
-
Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers
by: Feriel Azibani, et al.
Published: (2020-04-01) -
Cancer and Peripartum Cardiomyopathy
by: Jean-Luc Balligand, MD, PhD
Published: (2019-12-01) -
Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
by: Tobias J. Pfeffer, et al.
Published: (2021-08-01) -
Recurrent and Life-Threatening Peripartum Cardiomyopathy
by: Summer Aldrugh, MD, et al.
Published: (2020-04-01) -
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
by: Tobias J. Pfeffer, et al.
Published: (2023-02-01)